Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Clinical trial NCT07473128 · RECRUITING
Trial details
- NCT number
- NCT07473128
- Sponsor
- Pharmacosmos A/S
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.